Primary sex characteristics Biological traits directly involved in reproduction such as the testes and ovaries
Lilly's triple agonist retatrutide posts its strongest weight loss numbers yet, setting up a 2027 FDA filing Eli Lilly, this week, reported positive topline results from TRIUMPH-2 and TRIUMPH-3, two pivotal Phase 3 trials of retatrutide, a once-weekly injectable that activates receptors for GIP, GLP-1, and glucagon simultaneously a triple mechanism that no approved obesity therapy currently matches
Note: Certain medical conditions or medications may mean GLP-1 therapy is not right for you
12 Concluding Encouragement Taking charge of health with GLP-1 medications is a commendable step
Mc d thuc GLP-1 gip iu chnh s thm n, cc thi quen li sng lnh mnh vn ng vai tr quan trng
Values are the averages of three independent experiments performed in triplicateSEM